Compound Detail
CHEMBL1983268
ENTRECTINIB 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1
Basic Information
| ChEMBL ID | CHEMBL1983268 |
| Name | ENTRECTINIB |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | HAYYBYPASCDWEQ-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
74
Targets
194
Activities
4
Assay Types
29
PK Parameters
20
Publications
4
Known Names
10
Indications
3
Mechanisms
Molecular Properties
560.6
MW (Da)
5.03
ALogP
6
HBA
3
HBD
85.5
PSA (Ų)
0.29
QED
2
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2019 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Neurotrophic tyrosine kinase receptor inhibitor | INHIBITOR | Neurotrophic tyrosine kinase receptor | ✓ | ✓ |
| Proto-oncogene tyrosine-protein kinase ROS inhibitor | INHIBITOR | Proto-oncogene tyrosine-protein kinase ROS | ✓ | ✓ |
| ALK tyrosine kinase receptor inhibitor | INHIBITOR | ALK tyrosine kinase receptor | ✓ | ✓ |
Indications
Carcinoma, Non-Small-Cell Lung Neoplasms Neoplasms Carcinoma, Lobular Hematologic Neoplasms Melanoma Thyroid Neoplasms Glioma Leukemia, Myeloid, Acute Uveal Melanoma
ATC Classification
L01EX14
entrectinib
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Activity Summary
IC50 133 meas. best 9.7
Ki 56 meas. best 9.0
Kd 4 meas. best 8.7
EC50 1 meas. best 5.61
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Proto-oncogene tyrosine-protein kinase ROS CHEMBL5568 | IC50 | 9.7 | 8.2622 | 0.2 | 9 |
| High affinity nerve growth factor receptor CHEMBL2815 | IC50 | 9.66 | 8.6363 | 0.2 | 19 |
| ALK tyrosine kinase receptor CHEMBL4247 | Ki | 9.0 | 8.605 | 1.0 | 2 |
| BDNF/NT-3 growth factors receptor CHEMBL4898 | IC50 | 9.0 | 8.5767 | 1.0 | 9 |
| NT-3 growth factor receptor CHEMBL5608 | IC50 | 9.0 | 8.451 | 1.0 | 10 |
| ALK tyrosine kinase receptor CHEMBL4247 | IC50 | 8.8 | 7.5092 | 1.6 | 37 |
| High affinity nerve growth factor receptor CHEMBL2815 | Ki | 8.8 | 8.8 | 1.6 | 1 |
| NT-3 growth factor receptor CHEMBL5608 | Ki | 8.8 | 8.8 | 1.6 | 1 |
| Leukocyte tyrosine kinase receptor CHEMBL5627 | Ki | 8.8 | 8.8 | 1.6 | 1 |
| KM12 CHEMBL614709 | IC50 | 8.77 | 7.85 | 1.7 | 7 |
| High affinity nerve growth factor receptor CHEMBL2815 | Kd | 8.7 | 8.7 | 2.0 | 1 |
| BDNF/NT-3 growth factors receptor CHEMBL4898 | Ki | 8.6 | 8.6 | 2.5 | 1 |
| Tyrosine-protein kinase Fer CHEMBL3982 | Ki | 8.3 | 8.3 | 5.0 | 1 |
| Tyrosine-protein kinase FRK CHEMBL4223 | Ki | 7.8 | 7.8 | 15.8 | 1 |
| Tyrosine-protein kinase JAK2 CHEMBL2971 | Ki | 7.7 | 7.7 | 19.9 | 1 |
| SU-DHL-1 CHEMBL2366200 | IC50 | 7.7 | 7.7 | 20.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 7.62 | 7.34 | 24.0 | 5 |
| EML4-ALK CHEMBL3883330 | IC50 | 7.55 | 6.9233 | 28.0 | 3 |
| KARPAS-299 CHEMBL2366156 | IC50 | 7.51 | 7.315 | 31.0 | 2 |
| Proto-oncogene tyrosine-protein kinase Src CHEMBL267 | Ki | 7.5 | 7.5 | 31.6 | 1 |
| Activated CDC42 kinase 1 CHEMBL4599 | Ki | 7.5 | 7.5 | 31.6 | 1 |
| Serine/threonine-protein kinase PLK4 CHEMBL3788 | Ki | 7.4 | 7.4 | 39.8 | 1 |
| Macrophage colony-stimulating factor 1 receptor CHEMBL1844 | Ki | 7.4 | 7.4 | 39.8 | 1 |
| Tyrosine-protein kinase JAK2 CHEMBL2971 | IC50 | 7.4 | 7.4 | 40.0 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret CHEMBL2041 | Ki | 7.4 | 7.4 | 39.8 | 1 |
| Tyrosine-protein kinase receptor UFO CHEMBL4895 | Ki | 7.4 | 7.4 | 39.8 | 1 |
| Unchecked CHEMBL612545 | IC50 | 7.39 | 7.02 | 41.0 | 3 |
| Insulin-like growth factor 1 receptor CHEMBL1957 | Ki | 7.2 | 7.2 | 63.1 | 1 |
| NCI-H2228 CHEMBL1075536 | IC50 | 7.17 | 6.9767 | 68.0 | 3 |
| Activated CDC42 kinase 1 CHEMBL4599 | IC50 | 7.16 | 7.16 | 70.0 | 1 |
| MV4-11 CHEMBL613835 | IC50 | 7.09 | 7.09 | 81.0 | 1 |
| Focal adhesion kinase 1 CHEMBL2695 | Ki | 7.0 | 7.0 | 100.0 | 1 |
| Tyrosine-protein kinase JAK1 CHEMBL2835 | IC50 | 6.95 | 6.95 | 112.0 | 1 |
| Insulin-like growth factor 1 receptor CHEMBL1957 | IC50 | 6.91 | 6.6625 | 122.0 | 4 |
| Focal adhesion kinase 1 CHEMBL2695 | IC50 | 6.85 | 6.85 | 140.0 | 1 |
| STE20-like serine/threonine-protein kinase CHEMBL4202 | Ki | 6.8 | 6.8 | 158.5 | 1 |
| Tyrosine-protein kinase BTK CHEMBL5251 | Ki | 6.8 | 6.8 | 158.5 | 1 |
| Mast/stem cell growth factor receptor Kit CHEMBL1936 | Ki | 6.8 | 6.8 | 158.5 | 1 |
| Fibroblast growth factor receptor 3 CHEMBL2742 | Ki | 6.8 | 6.8 | 158.5 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | IC50 | 6.79 | 6.79 | 164.0 | 1 |
| Protein-tyrosine kinase 6 CHEMBL4601 | IC50 | 6.71 | 6.71 | 195.0 | 1 |
| Dual specificity protein kinase CLK4 CHEMBL4203 | Ki | 6.7 | 6.7 | 199.5 | 1 |
| Vascular endothelial growth factor receptor 3 CHEMBL1955 | Ki | 6.7 | 6.7 | 199.5 | 1 |
| Tyrosine-protein kinase Lyn CHEMBL3905 | Ki | 6.7 | 6.7 | 199.5 | 1 |
| Tyrosine-protein kinase Blk CHEMBL2250 | Ki | 6.7 | 6.7 | 199.5 | 1 |
| Insulin receptor CHEMBL1981 | IC50 | 6.68 | 6.68 | 209.0 | 1 |
| Aurora kinase A CHEMBL4722 | IC50 | 6.67 | 6.52 | 215.0 | 4 |
| Macrophage-stimulating protein receptor CHEMBL2689 | Ki | 6.6 | 6.6 | 251.2 | 1 |
| Aurora kinase A CHEMBL4722 | Ki | 6.6 | 6.6 | 251.2 | 1 |
| Fibroblast growth factor receptor 1 CHEMBL3650 | Ki | 6.6 | 6.6 | 251.2 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 10988.74 | ng.hr.mL-1 | Mus musculus |
| AUC | 9755.31 | ng.hr.mL-1 | Mus musculus |
| AUC | 8465.81 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 2876.13 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 9867.44 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 3195.7 | ng.hr.mL-1 | Canis lupus familiaris |
| CL | 33.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 87.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 13.5 | mL.min-1.kg-1 | Mus musculus |
| CL | 20.8 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 17.5 | mL.min-1.kg-1 | Canis lupus familiaris |
| Cmax | 4900.0 | nM | Mus musculus |
| Cmax | 1330.0 | nM | Mus musculus |
| Cmax | 11000.0 | nM | Rattus norvegicus |
| Cmax | 500.0 | nM | Rattus norvegicus |
| Cmax | 8600.0 | nM | Canis lupus familiaris |
| Cmax | 600.0 | nM | Canis lupus familiaris |
| F | 77.0 | % | Mus musculus |
| F | 43.0 | % | Rattus norvegicus |
| F | 32.0 | % | Canis lupus familiaris |
| T1/2 | 3.59 | hr | Mus musculus |
| T1/2 | 2.94 | hr | Mus musculus |
| T1/2 | 3.5 | hr | Rattus norvegicus |
| T1/2 | 3.8 | hr | Rattus norvegicus |
| T1/2 | 11.9 | hr | Canis lupus familiaris |
| T1/2 | 15.2 | hr | Canis lupus familiaris |
| Tmax | 2.5 | hr | Mus musculus |
| Tmax | 3.08 | hr | Rattus norvegicus |
| Tmax | 2.0 | hr | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine